508 A phase Ib trial of AMG386 and temsirolimus in patients with advanced sold tumors (PJC-008/NCI#9041)
Chiu, J.W, Hotte, S.J, Kollmannsberger, C.K, Renouf, D.J, Cescon, D.W, Hedley, D, Chow, S, Moscow, J, Perry, M, Diaz-Padilla, I, Tan, D, Hirte, H, McWhirter, E, Chen, H, Siu, L.L, Bedard, P.L
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
312 A Novel Assay for the Met Inhibitory Activity of MGCD265 in Plasma From Solid Tumor Patients in a Dose Escalating Phase I Study
Fournel, M, Wang, J, Beaulieu, N, Bonfils, C, Hurwitz, H, Shapiro, G, Kollmannsberger, C.K, Juretic, M, Besterman, J.M, Maroun, C.R
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, Robert J, Tannir, Nizar M, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Choueiri, Toni K, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, George, Saby, Powles, Thomas, Donskov, Frede, Neiman, Victoria, Kollmannsberger, Christian K, Salman, Pamela, Gurney, Howard, Hawkins, Robert, Ravaud, Alain, Grimm, Marc-Oliver, Bracarda, Sergio, Barrios, Carlos H, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Chen, Allen C, Mekan, Sabeen, McHenry, M. Brent, Wind-Rotolo, Megan, Doan, Justin, Sharma, Padmanee, Hammers, Hans J, Escudier, Bernard
Published in The New England journal of medicine (05.04.2018)
Published in The New England journal of medicine (05.04.2018)
Get full text
Journal Article
693P Plasma exosome microRNA-155-3p expression in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors: Potential biomarker of response to systemic therapy
Soleimani, M., Thi, M., Saxena, N., Khalaf, D.J., Eigl, B.J., Chi, K.N., Kollmannsberger, C.K., Nappi, L.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
LBA74 Final analysis of the phase III LITESPARK-005 study of belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC)
Rini, B.I., Suarez Rodriguez, C., Albiges, L., Jalkanen, K., De Velasco Oria, G.A., Burotto, M., Ghatalia, P., Iacovelli, R., Lam, E.T., Verzoni, E., Gumus, M., Stadler, W., Kollmannsberger, C.K., Melichar, B., Venugopal, B., Lin, J., Perini, R., Vickery, D., Choueiri, T.K., Powles, T.B.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1464P The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC)
Navani, V., Ernst, M.S., Takemura, K., Pal, S.K., Powles, T.B., Donskov, F., Wells, J.C., Kollmannsberger, C.K., Beuselinck, B., Alva, A.S., Weickhardt, A.J., Lalani, A-K., Ernst, D.S., Agarwal, N., Choueiri, T.K., Heng, D.Y.C.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1893P Immune-related adverse events from contemporary first-line combination therapies in metastatic renal cell carcinoma: Results from the IMDC
Navani, V., Lemelin, A., Powles, T.B., Liow, E.C.H., Wong, S.S.L., Meza, L.A., Ebrahimi, H., Saliby, R.M., Saad, E., Yuasa, T., Wood, L.A., Kollmannsberger, C.K., Graham, J., North, S., Basappa, N.S., Donskov, F., Rodriguez, C. Suarez, Lalani, A-K., Choueiri, T.K., Heng, D.Y.C.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study
Albiges, L., Rini, B.I., Peltola, K., De Velasco Oria, G.A., Burotto, M., Suarez Rodriguez, C., Ghatalia, P., Iacovelli, R., Lam, E.T., Verzoni, E., Gumus, M., Stadler, W.M., Kollmannsberger, C.K., Melichar, B., Venugopal, B., Wang, A., Perini, R., Vickery, D., Powles, T.B., Choueiri, T.K.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1903P Tumor response by baseline metastases in patients (pts) with renal cell carcinoma (RCC) treated with lenvatinib (L) plus pembrolizumab (P) vs sunitinib (S): Post hoc analysis of the CLEAR trial
Gruenwald, V., McKay, R.R., Buchler, T., Eto, M., Park, S.H., Takagi, T., Zanetta, S., Keizman, D., Rodriguez, C. Suarez, Negrier, S., Lee, J-L., Santini, D., Bedke, J., Staehler, M., Kollmannsberger, C.K., Choueiri, T.K., Motzer, R.J., Burgents, J., Okpara, C.E., Powles, T.B.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
661P Conditional survival and 5-year follow-up in CheckMate 214: First-line nivolumab + ipilimumab (N+I) versus sunitinib (S) in advanced renal cell carcinoma (aRCC)
Motzer, R.J., Tannir, N.M., McDermott, D.F., Burotto, M., Choueiri, T.K., Hammers, H.J., Plimack, E.R., Porta, C.G., George, S., Powles, T.B., Donskov, F., Gurney, H., Kollmannsberger, C.K., Grimm, M-O., Tomita, Y., Rini, B.I., McHenry, M.B., Lee, C-W., Escudier, B.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial
Tannir, N.M., Albigès, L., McDermott, D.F., Burotto, M., Choueiri, T.K., Hammers, H.J., Barthélémy, P., Plimack, E.R., Porta, C., George, S., Donskov, F., Atkins, M.B., Gurney, H., Kollmannsberger, C.K., Grimm, M.-O., Barrios, C., Tomita, Y., Castellano, D., Grünwald, V., Rini, B.I., Jiang, R., Desilva, H., Fedorov, V., Lee, C.-W., Motzer, R.J.
Published in Annals of oncology (01.11.2024)
Published in Annals of oncology (01.11.2024)
Get full text
Journal Article
Biological assessment of viable germ cell tumor (VT) in patients (pts) with seminoma (S) and non-seminoma (S) using miR371
Nappi, L., Thi, M., Fazli, L., Chi, K., Eigl, B., Nichols, C., Gleave, M., Kollmannsberger, C.K.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Differential expression of circulating miR375 and miR371 to detect teratoma and viable germ cell malignancy
Nappi, L., Thi, M., Eigl, B.J., Chi, K.N., Gleave, M.E., So, A., Black, P.C., Hamilton, R., Daneshmand, S., Nichols, C.R., Kollmannsberger, C.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
983P - Differential expression of circulating miR375 and miR371 to detect teratoma and viable germ cell malignancy
Nappi, L., Thi, M., Eigl, B.J., Chi, K.N., Gleave, M.E., So, A., Black, P.C., Hamilton, R., Daneshmand, S., Nichols, C.R., Kollmannsberger, C.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Efficacy of Enzalutamide (Enza) Following Abiraterone Acetate (Abi) in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients (Pts)
Azad, A.A., Eigl, B.J., Murray, N., Kollmannsberger, C.K., Chi, K.N.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
788PEFFICACY OF ENZALUTAMIDE (ENZA) FOLLOWING ABIRATERONE ACETATE (ABI) IN CHEMOTHERAPY-NAïVE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS (PTS)
Azad, A.A., Eigl, B.J., Murray, N., Kollmannsberger, C.K., Chi, K.N.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Circulating tumour DNA (ctDNA) utility as a biomarker for metastatic urothelial carcinoma (mUC)
Lavoie, J.-M., Vandekerkhove, G., Annala, M., Taavitsainen, S., Sundahl, N.L., Walz, S., Sano, T., Khalaf, D., Todenhöfer, T., Ost, P., Kollmannsberger, C.K., Chi, K.N., Black, P.C., Wyatt, A.W., Eigl, B.J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
908PD - Primary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC)
Albiges, L., Rini, B.I., Haanen, J B A G, Motzer, R.J., Kollmannsberger, C.K., Negrier, S., Nole, F., Bedke, J., Bilen, M.A., Nathan, P., Tomita, Y., Huang, B., Ching, K.A., Chudnovsky, A., Robbins, P.B., di Pietro, A., Thomaidou, D., Choueiri, T.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Primary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC)
Albiges, L., Rini, B.I., Haanen, J B A G, Motzer, R.J., Kollmannsberger, C.K., Negrier, S., Nole, F., Bedke, J., Bilen, M.A., Nathan, P., Tomita, Y., Huang, B., Ching, K.A., Chudnovsky, A., Robbins, P.B., di Pietro, A., Thomaidou, D., Choueiri, T.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND.226 study of durvalumab ± tremelimumab in combination with platinum-doublet chemotherapy
Hao, D., Ellis, P.M., Laurie, S.A., Juergens, R.A., Mates, M., Bradbury, P.A., Tsao, M., Tehfe, M., Kollmannsberger, C.K., Goffin, J.R., Wheatley-Price, P., Hilton, J., Robinson, A.G., Brown-Walker, P., Tu, D., Smoragiewicz, M., Seymour, L.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article